Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Health-hazard evaluation report HETA 80-035-1635b, Bofors-Nobel/Lakeway Corporation, Muskegon, Michigan (revised)

Technical Report ·
OSTI ID:6358125
The International Chemical Workers Union requested an evaluation of dermatitis and reproductive system disorders among workers exposed to oryzalin, dichlorobenzidine (DCB), and benzidine at the Bofors-Nobel/Lakeway facility, Muskegon, Michigan. Exposure to DCB was measured from two personal breathing samples and the results ranged from not detectable to 6.5 micrograms/cubic meter mcg/cu m. Area samples for DCB were also taken. Surface-contamination samples revealed DCB on the packout locker-room surfaces and inside the operator's personal-protective equipment. Exposure to airborne oryzalin for six full-shift workers ranged from not detectable to 130mg/cu m, with a mean of 28mcg cu m. Dinitrochlorobenzene (DNCB) was detected in air at 70mcg/cu m and on surfaces at 6mcg/100 cm/sup 2/. Workers exposed to oryzalin reported no adverse reproductive effects. Of 36 workers exposed to DNCB, 19 had skin problems. Bladder cancer was documented in 10 workers with a mean time from first exposure to benzidine to diagnosis of 13.3 years. The authors conclude that a potential hazard existed from dichlorobenzidine exposure. The authors recommend improved housekeeping explanation of the medical-surveillance program to all workers, and continuation of the bladder cancer screening program.
Research Organization:
National Inst. for Occupational Safety and Health, Cincinnati, OH (USA)
OSTI ID:
6358125
Report Number(s):
PB-87-163200/XAB; HETA-80-035-1635
Country of Publication:
United States
Language:
English